Public Citizen/FDA Settlement Will Speed Access To Advisory Committee Info
Executive Summary
Public access to advisory committee briefing information for non-confidential meetings will be allowed before or on the day of the meeting under a legal settlement between Public Citizen's Health Research Group and FDA. The legal settlement was reached July 6 and takes effect July 16.
You may also be interested in...
FDA Will Narrow Topics For Advisory Committees In Response To HRG Suit
FDA will ask more directed questions of its advisory committees as a way to narrow the amount of information from NDAs that will be provided to the committees, FDA's Office of Training and Communications Director Nancy Smith, PhD, told the Regulatory Affairs Professionals Society Oct. 5.
FDA Will Narrow Topics For Advisory Committees In Response To HRG Suit
FDA will ask more directed questions of its advisory committees as a way to narrow the amount of information from NDAs that will be provided to the committees, FDA's Office of Training and Communications Director Nancy Smith, PhD, told the Regulatory Affairs Professionals Society Oct. 5.
FDA Advisory Committee Triggers Should Be Spelled Out In Guidance - PhRMA
FDA should provide clear guidelines for what type of product applications will trigger an advisory committee review, the Pharmaceutical Research & Manufacturers of America said in Feb. 1 comments to FDA.